Arbuck SG - Search Results

1

Interleukin-2 lymphokine-activated killer cell therapy of non-Hodgkin's lymphoma and Hodgkin's disease.

Bernstein ZP, Vaickus L, Friedman N, Goldrosen MH, Watanabe H, Rahman R, Arbuck SG, Sweeney J, Vesper D, Henderson ED, et al. Bernstein ZP, et al. Among authors: arbuck sg. J Immunother (1991). 1991 Apr;10(2):141-6. doi: 10.1097/00002371-199104000-00008. J Immunother (1991). 1991. PMID: 2043594

2

Unusual gastrointestinal complications of interleukin-2 therapy.

Rahman R, Bernstein Z, Vaickus L, Penetrante R, Arbuck S, Kopec I, Vesper D, Douglass HO Jr, Foon KA. Rahman R, et al. J Immunother (1991). 1991 Jun;10(3):221-5. doi: 10.1097/00002371-199106000-00009. J Immunother (1991). 1991. PMID: 1868046

3

Interleukin-2 with ex vivo activated killer cells: therapy of advanced non-small-cell lung cancer.

Bernstein ZP, Goldrosen MH, Vaickus L, Friedman N, Watanabe H, Rahman R, Park J, Arbuck SG, Sweeney J, Vesper DS, et al. Bernstein ZP, et al. Among authors: arbuck sg. J Immunother (1991). 1991 Oct;10(5):383-7. doi: 10.1097/00002371-199110000-00012. J Immunother (1991). 1991. PMID: 1665077 Clinical Trial.

4

The effect of anti-CD3 on the induction of non-MHC restricted cytolytic activity.

Watanabe H, Narumi K, Stewart CC, Arbuck SG, Foon KA, Goldrosen MH. Watanabe H, et al. Among authors: arbuck sg. Anticancer Res. 1992 Nov-Dec;12(6B):1925-33. Anticancer Res. 1992. PMID: 1295440

5

A phase I clinical trial of recombinant human tumor necrosis factor given daily for five days.

Creaven PJ, Brenner DE, Cowens JW, Huben RP, Wolf RM, Takita H, Arbuck SG, Razack MS, Proefrock AD. Creaven PJ, et al. Among authors: arbuck sg. Cancer Chemother Pharmacol. 1989;23(3):186-91. doi: 10.1007/BF00267953. Cancer Chemother Pharmacol. 1989. PMID: 2924376

6

Selectivity of the micro-leukocyte adherence inhibition assay in pancreatic cancer.

Douglass HO Jr, Russo AJ, Howell JH, Moore MC, Arbuck SG, Chu TM, Goldrosen MH. Douglass HO Jr, et al. Among authors: arbuck sg. Cancer. 1979 Mar;43(3):1084-8. doi: 10.1002/1097-0142(197903)43:3<1084::aid-cncr2820430345>3.0.co;2-z. Cancer. 1979. PMID: 371783

7

Microplate leucocyte adherence inhibition (LAI) assay in pancreatic cancer: detection of specific antitumor immunity with patients' peripheral blood cells and serum.

Goldrosen MH, Dasmahapatra K, Jenkins D, Howell JH, Arbuck SG, Moore MC, Douglass HO Jr. Goldrosen MH, et al. Among authors: arbuck sg. Cancer. 1981 Mar 15;47(6 Suppl):1614-9. doi: 10.1002/1097-0142(19810315)47:6+<1614::aid-cncr2820471425>3.0.co;2-5. Cancer. 1981. PMID: 6168355 No abstract available.

8

A phase II trial of 5-fluorouracil, doxorubicin, mitomycin C, and leucovorin in advanced gastric carcinoma.

Arbuck SG, Silk Y, Douglass HO Jr, Nava H, Rustum YM, Milliron S. Arbuck SG, et al. Cancer. 1990 Jun 1;65(11):2442-5. doi: 10.1002/1097-0142(19900601)65:11<2442::aid-cncr2820651106>3.0.co;2-7. Cancer. 1990. PMID: 2337858

9

New drugs in non-Hodgkin's lymphoma.

Arbuck SG, Sorensen JM, Christian MC, Ho P, Pluda JM, Cheson BD. Arbuck SG, et al. Ann Oncol. 1997;8 Suppl 1:119-28. Ann Oncol. 1997. PMID: 9187445 Review.

10

Overview of clinical trials using 5-fluorouracil and leucovorin for the treatment of colorectal cancer.

Arbuck SG. Arbuck SG. Cancer. 1989 Mar 15;63(6 Suppl):1036-44. doi: 10.1002/1097-0142(19890315)63:6+<1036::aid-cncr2820631309>3.0.co;2-k. Cancer. 1989. PMID: 2645042 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

104 results

Search Page

Filters